Tag: Biotech

The “Plexiform Neurofibroma: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031” report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for the treatment... Read More

The “Familial Amyloid Polyneuropathy: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031” report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for the... Read More

The “PERK Inhibitor: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031” report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for the treatment... Read More

In 2018, seven out of ten top-selling prescription medicines were biologics. The liquid formulations of biologics are not much stable and tend to loose efficacy with time due to the... Read More

Roots Analysis is pleased to announce the publication of its recent study, titled, “Manufacturing Market Continuous (Small Molecules and Biologics), 2020 – 2030.” The report features an extensive study of the... Read More

To order this detailed 380+ page report, please visit this -https://www.rootsanalysis.com/reports/global-psychedelic-therapeutics-market.html Key Inclusions  A detailed assessment of the current market landscape of psychedelic therapeutics, providing information on phase of development (commercial, clinical,... Read More

Manufacturing live biotherapeutic product is both technically challenging and financially demanding; as a result, innovator firms are becoming increasingly reliant on contract service providers to access specialized facilities and optimize... Read More

Roots Analysis has announced the addition of “Human Factors Engineering and Usability Testing Services Market for Medical Devices, 2020-2030” report to its list of offerings The report features an extensive... Read More

With increasing cases of drug failure, due to problems associated with pharmacokinetic profiles of candidate therapies, absorption, distribution, metabolism and excretion (ADME) properties and inherent toxicity, industry players are actively... Read More

Repurposing of marketed / shelved / pipeline candidates for the treatment of diseases (different from original target indications) has emerged as a viable business strategy. The rising popularity of this... Read More